Logo
Tratamientos

Fuentes válidas para respaldar esos datos

EURORDIS – Rare Barometer Surveys, 2. Global Genes – Rare Disease Facts, 3. Orphanet (INSERM – Francia)
Datos basados en estudios internacionales de EURORDIS y Orphanet sobre retraso diagnóstico en enfermedades raras.

SHUa (Síndrome Hemolítico Urémico Atípico)

1. National Organization for Rare Disorders (NORD), 2. Orphanet – aHUS, 3. KDIGO (Kidney Disease: Improving Global Outcomes)

HPN (Hemoglobinuria Paroxística Nocturna)

1. American Society of Hematology (ASH), 2. NORD – Paroxysmal Nocturnal Hemoglobinuria, 3. NIH – Genetic and Rare Diseases Information Center (GARD)

HPP (Hipofosfatasia)

1. Soft Bones Foundation (US HPP Foundation), 2. Orphanet – Hypophosphatasia, 3. NIH – GARD (Genetic and Rare Diseases Information Center)

LAL-D (Deficiencia de Lipasa Ácida Lisosomal)

1. NORD – Lysosomal Acid Lipase Deficiency, 2. Orphanet – LAL-D, 3. European Association for the Study of the Liver (EASL)

CONCEPTO MÉDICO (DIAGNÓSTICO DIFERENCIAL, RETRASO DIAGNÓSTICO)

1. National Academy of Medicine (Improving Diagnosis in Health Care, 2015), 2. WHO – Patient Safety: Diagnostic Errors, 3. The Lancet Commission on Diagnostic Error